OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,237 | -72.5% | 24,020 | -71.9% | 0.00% | – |
Q2 2021 | $335,000 | +161.7% | 85,566 | +167.0% | 0.00% | – |
Q1 2021 | $128,000 | +70.7% | 32,052 | -1.4% | 0.00% | – |
Q4 2020 | $75,000 | -50.7% | 32,492 | +23.0% | 0.00% | – |
Q3 2020 | $152,000 | -5.0% | 26,418 | +21.3% | 0.00% | – |
Q2 2020 | $160,000 | +66.7% | 21,785 | -6.0% | 0.00% | – |
Q4 2019 | $96,000 | +190.9% | 23,165 | +125.6% | 0.00% | – |
Q3 2019 | $33,000 | +450.0% | 10,269 | +208.3% | 0.00% | – |
Q2 2019 | $6,000 | -98.7% | 3,331 | -98.7% | 0.00% | – |
Q1 2019 | $454,000 | +263.2% | 257,262 | +394.4% | 0.00% | – |
Q4 2018 | $125,000 | -95.5% | 52,032 | -89.5% | 0.00% | -100.0% |
Q3 2018 | $2,795,000 | -40.9% | 493,427 | -18.6% | 0.00% | 0.0% |
Q2 2018 | $4,727,000 | +126.3% | 606,245 | +105.0% | 0.00% | 0.0% |
Q1 2018 | $2,089,000 | +0.3% | 295,722 | +40.1% | 0.00% | 0.0% |
Q4 2017 | $2,082,000 | +18.9% | 211,101 | +3.2% | 0.00% | 0.0% |
Q3 2017 | $1,751,000 | -18.8% | 204,494 | -0.6% | 0.00% | -50.0% |
Q2 2017 | $2,157,000 | – | 205,826 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |